2018年圣安东尼奥乳腺癌研讨会（SABCS）即将于2018年12月4日-8日在美国圣安东尼奥召开，SABCS是世界上最大、最具影响力的乳腺癌会议。从1977年开始至今，已经发展成为为期5天，来自世界90多个国家超过7000名科研人员与医生代表参与的研讨会。【肿瘤资讯】将为大家带来SABCS 2018相关资讯，届时小编将奔赴SABCS 2018现场为大家带来现场报道，敬请期待。
Oral Session：General Session 5
Date：Friday，December 7，2018
Time：09:45 AM-11:30 AM
Room：Hall 3
摘要编号：GS5-01
A randomized community-based trial of an angiotensin converting enzyme inhibitor, lisinopril or a beta blocker, carvedilol for the prevention of cardiotoxicity in patients with early stage HER2-positive breast cancer receiving adjuvant trastuzumab
一项基于社区的随机试验：ACEI、lisinopril或一种β受体阻滞剂，carvedilol用于预防接受曲妥珠单抗辅助治疗早期HER2阳性乳腺癌患者心脏毒性
09：45 AM
摘要编号：GS5-02
Cardiovascular function and the effect of exercise training during adjuvant breast cancer treatment. Results from The EBBA-II trial
EBBA-II试验的结果：辅助乳腺癌治疗过程中心血管功能及运动训练的效果
10：00 AM
摘要编号：GS5-03
Lifestyle Intervention and Effect on Disease-free Survival in Early Breast Cancer Pts: Interim Analysis from the Randomized SUCCESS C Study
随机SUCCESS C研究的中期分析：生活方式干预对早期乳腺癌患者无病生存的影响
10：15 AM
摘要编号：GS5-04
discussant Ligibel 811, 786 & 761
10：30 AM
摘要编号：GS5-05
Resistance to neoadjuvant chemotherapy in triple negative breast cancer mediated by a reversible drug-tolerant state
由可逆的药物耐受状态介导的对三阴性乳腺癌新辅助化疗耐药的研究
10：45 AM
摘要编号：GS5-06
No survival benefit of chemotherapy escalation in patients with pCR and “high-immune” triple-negative early breast cancer in the neoadjuvant WSG-ADAPT-TN trial
新辅助治疗WSG-ADAPT-TN试验：pCR和“高免疫”三阴性早期乳腺癌患者化疗升级无生存获益
11：00 AM
摘要编号：GS5-07
International pooled analysis of the prognostic impact of disseminated tumor cells from the bone marrow in early breast cancer: Results from the PADDY study
PADDY研究结果:国际汇总分析早期乳腺癌中骨髓播散性肿瘤细胞的预后影响
11：15 AM
Session：Oral Session：General Session 6
Date：Friday，December 7，2018
Time：03：15 PM-05:00 PM
Room：Hall 3
摘要编号：GS6-01
Surgical treatment after neoadjuvant systemic therapy in young women with breast cancer: Results from a prospective cohort study
一项年轻女性乳腺癌新辅助全身治疗后手术治疗的前瞻性队列研究结果
03：15 PM
摘要编号：GS6-02
A randomized, double-blind, placebo-controlled trial of oxybutynin (Oxy) for hot flashes (HF): ACCRU study SC-1603
ACCRU研究SC-1603：奥昔布宁（Oxy）用于潮热（HF）的随机，双盲，安慰剂对照试验
03：30 PM
摘要编号：GS6-03
Symptoms and health-related quality of life on endocrine therapy alone (E) versus chemoendocrine therapy (C+E): TAILORx patient-reported outcomes results
TAILORx患者报告结果：仅内分泌治疗(E)对比化学内分泌治疗（C+E）的症状和健康相关生活质量
03：45 PM
摘要编号：GS6-04
Development and validation of a chemotherapy toxicity (Chemo Tox) risk score for older patients (Pts) with breast cancer (BC) receiving adjuvant/neoadjuvant treatment (Adjuvant Tx): A R01 and BCRF funded prospective multicenter study
R01和BCRF资助的前瞻性多中心研究：开发和验证接受辅助/新辅助治疗的乳腺癌（BC）老年患者（Pts）的化疗毒性（Chemo Tox）风险评分（辅助Tx）
04：00 PM
摘要编号：GS-05
The impact of breast cancer surgery on quality of life: Long term results from E5103
E5103的长期结果：乳腺癌手术对生活质量的影响
04：15 PM
摘要编号：GS6-06
Local therapy and quality of life outcomes in young women with breast cancer
乳腺癌年轻女性的局部治疗和生活质量结果
04：30 PM
摘要编号：GS6-07
Discussant Ganz 516 & 1359
04：45 PM
【SABCS 2018】即将开幕，敬请期待相关报道！
苏公网安备32059002004080号
